Earnings
Tempus AI, Inc. (NASDAQ: TEM) Reports Robust Q2 Results, Outperforms Expectations
Tempus AI, Inc. reported a strong second quarter in 2025 with revenue exceeding expectations and a narrowed net loss.
BTC$64,354.00-0.93%
ETH$1,875.11-2.02%
USDT$0.9993+0.02%
USDC$0.9999+0.00%
XRP$1.11-0.37%
SOL$76.11-1.64%
TRX$0.3231-0.31%
FIGR_HELOC$1.04-0.04%
HYPE$64.20-4.62%
DOGE$0.0733-0.39%
USDS$0.9998+0.00%
ZEC$553.68-3.33%
RAIN$0.0139-3.98%
LEO$9.83+0.14%
WBT$56.26-1.04%
BTC$64,354.00-0.93%
ETH$1,875.11-2.02%
USDT$0.9993+0.02%
USDC$0.9999+0.00%
XRP$1.11-0.37%
SOL$76.11-1.64%
TRX$0.3231-0.31%
FIGR_HELOC$1.04-0.04%
HYPE$64.20-4.62%
DOGE$0.0733-0.39%
USDS$0.9998+0.00%
ZEC$553.68-3.33%
RAIN$0.0139-3.98%
LEO$9.83+0.14%
WBT$56.26-1.04%
Policy tailwinds and precision medicine breakthroughs are pushing healthcare stocks like Tempus AI and CRISPR Therapeutics into a new era of growth.
Tempus AI, Inc. reported a strong second quarter in 2025 with revenue exceeding expectations and a narrowed net loss.